News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Corporation (NVS) To Buy Superbug Firm NeuTec Pharma plc (NTP.L) For $569 Million



6/7/2006 10:33:43 AM

ZURICH/LONDON, June 7 (Reuters) - Novartis AG (NOVN.VX: Quote, Profile, Research) boosted its infectious diseases portfolio on Wednesday by agreeing to buy British firm NeuTec Pharma Plc (NTP.L: Quote, Profile, Research), a specialist in fighting hospital superbugs, for $569 million.


Read at Reuters
Read at canada.com
Read at Earthtimes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES